4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001910662-25-000003
SVP, CHIEF FINANCIAL OFFICER sold 2,227 shares at an average $77.95 ($173,584)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
LaBrosse Nicole · SVP, CHIEF FINANCIAL OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-22 | Sale : show line 1 in the form 10b5-1 | −1,913 | $77.83 | $148,883 | 22,393 | D |
| 2025-09-22 | Sale : show line 2 in the form 10b5-1 | −314 | $78.67 | $24,701 | 22,079 | D |
| Open-market sales · 2,227 sh · avg $77.95 · $173,584 | ||||||
Loading xslF345X05/form4-09232025_080958.xml…